At
the request of countries' ministries of health and leading health care
providers,
Venture Strategies is creating access to the generic drug, misoprostol, for
postpartum hemorrhage in developing countries throughout Africa and
Asia. Registration is a key strategy to improving access to this
life-saving drug in the countries where misoprostol is needed most: low
resource countries with high rates of home births, unattended by
skilled
providers; and countries that witness tragic numbers of maternal deaths
annually. Additionally, we are working with local distributors in Asia and Africa and generic
manufacturers to establish south-south routes and
methods of making misoprostol and other needed generic drugs available
in pharmacies and drug shops outside urban areas.
Venture Strategies works actively with governments, agencies, and women’s groups to enable women to have control over whether and when to have a child, by reducing barriers to access to fertility regulation methods and the needed correct information. In our view, poor women should not be exposed to the dangers and exploitation of unsafe abortion. We also value participation of the private sector at the community level for improving health care. Project Areas: We are expanding understanding in the policy community of the importance of population growth, determinants of fertility decline, and the many unnecessary barriers to family planning. In collaboration with the School of Public Health at the University of California, Berkeley, we have published the first comprehensive review of the wide range of barriers standing between low income women around the world and the family planning methods they want. Parliamentary Hearings—Venture Strategies’ president recently was special advisor to the member of the UK Parliament who convened hearings on rapid population growth in the world's least developed countries. The report was published in 2007 as Return of the Population Growth Factor: Its Impact upon the Millennium Development Goals (The full report and the barriers article are available under publications in our web site.)
Venture Strategies has completed a large evaluation in Western Uganda of an output-based assistance (OBA) program that incorporates voucher incentives for patients and performance contracts with providers.
|
|
